# Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women

> **NCT06911034** · PHASE4 · COMPLETED · sponsor: **CMH Multan Institute of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- Iron Deficiency Anemia (IDA)
- Pregnancy

## Interventions

- **DRUG:** Iron Carboxymaltose
- **DRUG:** Iron Sucrose Injection

## Key facts

- **NCT ID:** NCT06911034
- **Lead sponsor:** CMH Multan Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-09-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06911034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06911034, "Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06911034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*